Correlation Between Pennant and Surgery Partners

Can any of the company-specific risk be diversified away by investing in both Pennant and Surgery Partners at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pennant and Surgery Partners into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Pennant Group and Surgery Partners, you can compare the effects of market volatilities on Pennant and Surgery Partners and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pennant with a short position of Surgery Partners. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pennant and Surgery Partners.

Diversification Opportunities for Pennant and Surgery Partners

-0.14

Correlation Coefficient

Pennant  Surgery Partners

Good diversification

The 3 months correlation between Pennant and Surgery is -0.14. Overlapping area represents the amount of risk that can be diversified away by holding Pennant Group and Surgery Partners in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Surgery Partners and Pennant is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pennant Group are associated (or correlated) with Surgery Partners. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Surgery Partners has no effect on the direction of Pennant i.e., Pennant and Surgery Partners go up and down completely randomly.

Pair Corralation between Pennant and Surgery Partners

Given the investment horizon of 90 days Pennant Group is expected to under-perform the Surgery Partners. But the stock apears to be less risky and, when comparing its historical volatility, Pennant Group is 1.73 times less risky than Surgery Partners. The stock trades about -0.15 of its potential returns per unit of risk. The Surgery Partners is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest  2,384  in Surgery Partners on November 28, 2024 and sell it today you would earn a total of  121.00  from holding Surgery Partners or generate 5.08% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Pennant Group  vs.  Surgery Partners

Pennant Group

Risk-Adjusted Performance

Very Weak

Over the last 90 days Pennant Group has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unsteady performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in March 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Surgery Partners

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Surgery Partners are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of fairly fragile basic indicators, Surgery Partners may actually be approaching a critical reversion point that can send shares even higher in March 2025.

Pair Trading with Pennant and Surgery Partners

The main advantage of trading using opposite Pennant and Surgery Partners positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pennant position performs unexpectedly, Surgery Partners can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Surgery Partners will offset losses from the drop in Surgery Partners' long position.

The idea behind Pennant Group and Surgery Partners pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.